Early CPAP versus surfactant in extremely preterm infants.
There are limited data to inform the choice between early treatment with continuous positive airway pressure (CPAP) and early surfactant treatment as the initial support for extremely-low-birth-weight infants. We performed a randomized, multicenter trial, with a 2-by-2 factorial design, involving infants who were born between 24 weeks 0 days and 27 weeks 6 days of gestation. Infants were randomly assigned to intubation and surfactant treatment (within 1 hour after birth) or to CPAP treatment initiated in the delivery room, with subsequent use of a protocol-driven limited ventilation strategy. Infants were also randomly assigned to one of two target ranges of oxygen saturation. The primary outcome was death or bronchopulmonary dysplasia as defined by the requirement for supplemental oxygen at 36 weeks (with an attempt at withdrawal of supplemental oxygen in neonates who were receiving less than 30% oxygen). A total of 1316 infants were enrolled in the study. The rates of the primary outcome did not differ significantly between the CPAP group and the surfactant group (47.8% and 51.0%, respectively; relative risk with CPAP, 0.95; 95% confidence interval [CI], 0.85 to 1.05) after adjustment for gestational age, center, and familial clustering. The results were similar when bronchopulmonary dysplasia was defined according to the need for any supplemental oxygen at 36 weeks (rates of primary outcome, 48.7% and 54.1%, respectively; relative risk with CPAP, 0.91; 95% CI, 0.83 to 1.01). Infants who received CPAP treatment, as compared with infants who received surfactant treatment, less frequently required intubation or postnatal corticosteroids for bronchopulmonary dysplasia (P<0.001), required fewer days of mechanical ventilation (P=0.03), and were more likely to be alive and free from the need for mechanical ventilation by day 7 (P=0.01). The rates of other adverse neonatal outcomes did not differ significantly between the two groups. The results of this study support consideration of CPAP as an alternative to intubation and surfactant in preterm infants. (ClinicalTrials.gov number, NCT00233324.)
129 investigators, click to expand
19 references, click to expand
-
Resuscitation and ventilation strategies for extremely preterm infants: a comparison study between two neonatal centers in Boston and Stockholm.Acta Paediatr. 2007 Jan;96(1):10-6; discussion 8-9 PMID: 17187596
-
Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia.J Perinatol. 2003 Sep;23(6):451-6 PMID: 13679930
-
Multicenter trial of early treatment for retinopathy of prematurity: study design.Control Clin Trials. 2004 Jun;25(3):311-25 PMID: 15157731
-
Neonatal care of very-low-birthweight infants in special-care units and neonatal intensive-care units in Stockholm. Early nasal continuous positive airway pressure versus mechanical ventilation: gains and losses.Acta Paediatr Suppl. 1997 Apr;419:4-10 PMID: 9185897
-
Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants.Cochrane Database Syst Rev. 2000;(2):CD000511 PMID: 10796380
-
Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial.Pediatrics. 2004 Sep;114(3):651-7 PMID: 15342835
-
Target ranges of oxygen saturation in extremely preterm infants.N Engl J Med. 2010 May 27;362(21):1959-69 PMID: 20472937
-
Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.Cochrane Database Syst Rev. 2001;(2):CD000510 PMID: 11405966
-
Nasal CPAP or intubation at birth for very preterm infants.N Engl J Med. 2008 Feb 14;358(7):700-8 PMID: 18272893
-
Neurodevelopmental outcome and pulmonary morbidity two years after early versus late surfactant treatment: does it really differ?Acta Paediatr. 2009 Apr;98(4):654-9 PMID: 19170659
-
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.Cochrane Database Syst Rev. 2000;(2):CD001456 PMID: 10796266
-
Impact of a physiologic definition on bronchopulmonary dysplasia rates.Pediatrics. 2004 Nov;114(5):1305-11 PMID: 15520112
-
Is it safer to intubate premature infants in the delivery room?Pediatrics. 2005 Jun;115(6):1660-5 PMID: 15930230
-
Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network.Pediatrics. 2000 Jun;105(6):1194-201 PMID: 10835057
-
Changes in intubation rates and outcome of very low birth weight infants: a population-based study.Pediatrics. 1996 Jul;98(1):24-7 PMID: 8668407
-
Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low birth weight infants.Eur J Pediatr. 1997 May;156(5):384-8 PMID: 9177982
-
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004454 PMID: 16856047
-
Is chronic lung disease in low birth weight infants preventable? A survey of eight centers.Pediatrics. 1987 Jan;79(1):26-30 PMID: 3797169
-
Continuous distending pressure for respiratory distress syndrome in preterm infants.Cochrane Database Syst Rev. 2002;(2):CD002271 PMID: 12076445
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: [email protected]
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
